ALL Flashcards
Endocrine chemical pathology A Prolactinoma B Grave’s disease C Addison’s disease D Schmidst’s syndrome E Acromegaly F Conn’s syndrome G Kallman’s syndrome H Secondary hypoaldosteronism I De Quervain’s thyroiditis A 46-year-old man is seen by his GP after experiencing tremors, heat intolerance and weight loss. His wife complained that his eyes were bulging. Blood tests reveal T3 (1.2–3.0 nmol/L), T4 (70–140 nmol/L), TSH (0.5–5.7 mIU/L).
B Grave’s disease Grave’s disease (B) is an autoimmune condition resulting in the production of TSH-receptor antibodies, leading to elevated levels of T3 and T4. TSH levels will therefore be suppressed as a result of negative feedback. Clinical features will include exophthalmos, pretibial myxoedema, diffuse thyroid enlargement as well as other systemic features of hyperthyroiditis (tremor, excess sweating, heat intolerance and unintentional weight loss). There is a strong association with other autoimmune conditions such as vitiligo and type 1 diabetes mellitus.
Potassium handling A Spurious sample B Anorexia C Diarrhoea D Renal tubular acidosis E Insulin overdose F Bartter syndrome G Frusemide H Renal failure I ACE inhibitors A 68-year-old woman on the Care of the Elderly ward is found to have the following blood results: Na 138 (135–145 mmol/L) K 3.0 (3.5–5.0 mmol/L) Urea 4.2 (3.0–7.0 mmol/L) Creatinine 74 (60–120 mmol/L) pH 7.31 (7.35–7.45) HCO3 28 (22–28 mmol/L)
D Renal tubular acidosis Renal tubular acidosis (D) occurs when there is a defect in hydrogen ion secretion into the renal tubules. Potassium secretion into the renal tubules therefore increases to balance sodium reabsorption. This results in hypokalaemia with acidosis. Renal tubular acidosis is classified according to the location of the defect: type 1 (distal tubule), type 2 (proximal tubule), type 3 (both distal and proximal tubules). Type 4 results from a defect in the adrenal glands and is included in the classification as it results in a metabolic acidosis and hyperkalaemia.
Acid–base balance A Metabolic acidosis B Metabolic acidosis with respiratory compensation C Metabolic alkalosis D Metabolic alkalosis with respiratory compensation E Respiratory acidosis F Respiratory acidosis with metabolic compensation G Respiratory alkalosis H Respiratory alkalosis with metabolic compensation I Mixed metabolic and respiratory acidosis pH 7.31 (7.35–7.45) pO2 7.6 (10.6–13 kPa) pCO2 8.2 (4.7–6.0 kPa) HCO3 26 (22–28 mmol/L)
E Respiratory acidosis Respiratory acidosis (E) is defined by a low pH (acidosis) together with a high pCO2, due to carbon dioxide retention secondary to a pulmonary, neuromuscular or physical causes. There is no metabolic compensation in this case, suggesting this is an acute pathology; a compensatory metabolic rise in HCO3 from the kidneys can take hours or days. This patient is also hypoxic with a low pO2. Causes of an acute respiratory acidosis include an acute exacerbation of asthma, foreign body obstruction and cardiac arrest.
Plasma proteins A Bence–Jones protein B Carcino-embryonic antigen C Caeruloplasmin D Fibrinogen E Amylase F Ferritin G α-Fetoprotein H Albumin I CA125 A 62-year-old smoker with a history of ulcerative colitis presents to his GP with weight loss and tiredness. The patient admits noticing fresh blood mixed in with the stool.
A Bence–Jones protein Bence–Jones proteins (A) are monoclonal globular proteins that are a diagnostic feature of multiple myeloma. Multiple myeloma is defined as the proliferation of plasma cells in the bone marrow and is commonly associated with the elderly population. Malignant plasma cells produce monoclonal antibodies and/or κ or λ light chains (paraproteins). The light chains appear in the urine and can be detected by electrophoresis of a urine sample as a monoclonal band. Bence–Jones proteins are also a feature of Waldenstrom’s macroglobulinaemia and amyloid light chain amyloidosis.
Endocrine chemical pathology A Prolactinoma B Grave’s disease C Addison’s disease D Schmidst’s syndrome E Acromegaly F Conn’s syndrome G Kallman’s syndrome H Secondary hypoaldosteronism I De Quervain’s thyroiditis A 38-year-old woman is referred by her GP to the Endocrine Clinic for further tests after experiencing fatigue and orthostatic hypotension. After a positive short synACTHen test, a long synACTHen test reveals a cortisol of 750 nmol/L after 24 hours.
C Addison’s disease Addison’s disease (C) is caused by primary adrenal insufficiency resulting in a reduced production of cortisol and aldosterone. It is diagnosed using the synACTHen test. In the short synACTHen test, baseline plasma cortisol is measured at 0 minutes, the patient is given 250 μg of synthetic ACTH at 30 minutes and plasma cortisol is rechecked at 60 minutes; if the final plasma cortisol is
Inborn errors of metabolism A Phenylketonuria (PKU) B Peroxisomal disorders C Maple syrup urine disease D Short-chain acyl-coenzyme A dehydrogenase (SCAD) deficiency E Von Gierke’s disease F Fabry’s disease G Urea cycle disorder H Homocystinuria I Galactosaemia A 14-day-old girl of Jewish descent presents with lethargy, poor feeding and hypotonia. The paediatrician examining the child also notices excessively sweaty feet.
C Maple syrup urine disease Maple syrup urine disease (C) is an organic aciduria, a group of disorders that represent impaired metabolism of leucine, isoleucine and valine. As a result, toxic compounds accumulate causing toxic encephalopathy which manifests as lethargy, poor feeding, hypotonia and/or seizures. Characteristic of maple syrup urine disease are a sweet odour and sweaty feet. The gold standard diagnostic test is gas chromatography with mass spectrometry. Management involves the avoidance of the causative amino acids.
Therapeutic drug monitoring A Procainamide B Lithium C Methotrexate D Theophylline E Gentamicin F Carbamazepine G Cyclosporine H Phenytoin I Digoxin A 35-year-old man presents to accident and emergency with feelings of lightheadedness and slurred speech. His wife mentions that the patient has been walking around ‘like a drunk’. The man’s blood pressure is found to be low.
H Phenytoin Phenytoin (H) is a commonly used anti-epileptic agent. Serum levels of phenytoin must be monitored due to its narrow therapeutic range (10–20 μg/mL). Phenytoin also exhibits saturation kinetics; a small rise in dose may lead to saturation of metabolism by CYP enzymes in the liver, hence producing a large increase in drug concentration in the blood as well as associated toxic effects. Phenytoin toxicity can lead to hypotension, heart block, ventricular arrhythmias and ataxia.
Anion gap A patient has the following blood results; calculate the anion gap: Na 143 mmol/L K 4 mmol/L Cl 107 mmol/L HCO3 25 mmol/L PO4 1 mmol/L Glucose 8 mmol/L Urea 7 mmol/L A 14 mmol/L B 15 mmol/L C 16 mmol/L D 17 mmol/L E Not enough information
A 14 mmol/L The anion gap is calculated using the following equation: Anion gap = [Na+] + [K+] − [HCO3] − [Cl−] It is a method of assessing the contribution of unmeasured anions in metabolic acidosis. The normal range varies between laboratories but the upper limit is usually between 10 and 18 mmol/L. It is helpful to estimate the unmeasured anions such as phosphate, ketones and lactate which are difficult to measure normally.
Inborn errors of metabolism A Phenylketonuria (PKU) B Peroxisomal disorders C Maple syrup urine disease D Short-chain acyl-coenzyme A dehydrogenase (SCAD) deficiency E Von Gierke’s disease F Fabry’s disease G Urea cycle disorder H Homocystinuria I Galactosaemia A 5-month-old boy is seen by the community paediatrician due to concerns of developmental delay. On examination dysmorphic features are noted, as well as a ‘cherry-red spot’ on the baby’s trunk.
F Fabry’s disease Fabry’s disease (F) is a lysosomal storage disorder in which there is deficiency in α-galactosidase. Presentation is almost always a child with developmental delay together with dysmorphia. Other findings may involve movement abnormalities, seizures, deafness and/or blindness. On examination, hepatosplenomegaly, pulmonary and cardiac problems may be noted. The pathognomonic feature of lysosomal storage disorders is the presence of a ‘cherry-red spot’.
Endocrine chemical pathology A Prolactinoma B Grave’s disease C Addison’s disease D Schmidst’s syndrome E Acromegaly F Conn’s syndrome G Kallman’s syndrome H Secondary hypoaldosteronism I De Quervain’s thyroiditis A 48-year-old man visits his GP complaining of muscle pain and weakness. He is found to have raised blood pressure. Blood tests reveal Na 149 (135– 145 mmol/L) and K 3.1 (3.5–5.0 mmol/L).
F Conn’s syndrome Conn’s syndrome (F) is defined as primary hyperaldosteronism secondary to an aldosterone-producing adrenal adenoma. As a result of the high aldosterone levels produced there will be an increased excretion of potassium and reabsorption of sodium, leading to hypokalaemia and hypernatraemia. The increased delivery of sodium to the juxtaglomerular apparatus causes renin levels to be reduced. Plasma aldosterone will either be raised or inappropriately normal (as ACTH is suppressed, aldosterone should physiologically be reduced).
Acid–base balance A Metabolic acidosis B Metabolic acidosis with respiratory compensation C Metabolic alkalosis D Metabolic alkalosis with respiratory compensation E Respiratory acidosis F Respiratory acidosis with metabolic compensation G Respiratory alkalosis H Respiratory alkalosis with metabolic compensation I Mixed metabolic and respiratory acidosis pH 7.30 (7.35–7.45) pO2 8.2 (10.6–13 kPa) pCO2 7.2 (4.7–6.0 kPa) HCO3 19 (22–28 mmol/L)
I Mixed metabolic and respiratory acidosis Mixed metabolic and respiratory acidosis (I) occurs when there is a low pH and a simultaneous high pCO2 and low HCO3. In the case of a mixed metabolic and respiratory acidosis, the metabolic acidosis component may be due to conditions such as uraemia, ketones produced as a result of diabetes mellitus or renal tubular acidosis. The respiratory acidosis component may be due to any cause of respiratory failure. Hence, this mixed picture may occur in a COPD patient with concurrent diabetes mellitus.
Potassium handling A Spurious sample B Anorexia C Diarrhoea D Renal tubular acidosis E Insulin overdose F Bartter syndrome G Frusemide H Renal failure I ACE inhibitors A 15-year-old boy presents to accident and emergency with loss of consciousness. His blood sugars are found to be extremely low. Blood tests demonstrate the following: Na 138 (135–145 mmol/L) K 3.0 (3.5–5.0 mmol/L) Urea 4.2 (3.0–7.0 mmol/L) Creatinine 74 (60–120 mmol/L) pH 7.48 (7.35–7.45) HCO3 31 (22–28 mmol/L)
E Insulin overdose Insulin overdose (E) in a diabetic patient will cause a redistributive hypokalaemia and concurrent metabolic alkalosis. Insulin causes a shift of potassium ions from the extracellular space to the intracellular space, thereby lowering blood potassium levels. Metabolic alkalosis can also cause a redistributive hypokalaemia; a reduced hydrogen ion concentration in the blood causes increased intracellular hydrogen ion loss to increase extracellular levels via Na+/H+ ATPase; potassium ions therefore diffuse intracellularly to maintain the electrochemical potential. Adrenaline and re-feeding syndrome also cause redistributive hypokalaemia.
Therapeutic drug monitoring A Procainamide B Lithium C Methotrexate D Theophylline E Gentamicin F Carbamazepine G Cyclosporine H Phenytoin I Digoxin A 45-year-old man presents to his GP for a routine medications review. The patient complains of recent diarrhoea and headaches. The GP notes the patient was treated with erythromycin for a community acquired pneumonia 1 week previous to the consultation.
D Theophylline Theophylline (D) is a drug used in the treatment of asthma and COPD. A low therapeutic index and wide variation in metabolism between patients lead to requirement for drug monitoring. Toxicity may manifest in a number of ways including nausea, diarrhoea, tachycardia, arrhythmias and headaches. Severe toxicity may lead to seizures. The toxic effects of theophylline are potentiated by erythromycin and ciprofloxacin. Without monitoring, many patients would be under-treated.
Vitamin deficiencies A Vitamin A B Vitamin B1 C Vitamin B2 D Vitamin B6 E Vitamin B12 F Vitamin C G Vitamin D H Vitamin E I Vitamin K A 26-year-old man presents to his GP with a 5-month history of bleeding gums. Petechiae are also observed on the patient’s feet. The man admits he has had to visit his dentist recently due to poor dentition
F Vitamin C Vitamin C (F) is a water soluble vitamin, essential for the hydroxylation of collagen. When deficiency of vitamin C is present, collagen is unable to form a helical structure and hence cannot produce cross-links. As a consequence, damaged vessels and wounds are slow to heal. Vitamin C deficiency results in scurvy, which describes both bleeding (gums, skin and joints) and bone weakness (microfractures and brittle bones) tendencies. Gum disease is also a characteristic feature.
Thyroid function tests A 45-year-old woman presents feeling tired all of the time. She has been investigated for anaemia which reveals macrocytosis. She denies drinking excessively. She has recently moved house and the GP notices she has a croaky voice, peaches and cream complexion and a slowed reaction to his questions. He examines her and elicits slow relaxing ankle reflexes. He suspects hypothyroidism and orders some thyroid function tests. Which of the following results are consistent with primary hypothyroidism? A Low TSH, raised free T4 and T3 B Low or normal TSH with low free T4 and T3 C Raised TSH with normal free T4 and T3 D Normal or raised TSH with raised T4 and T3 E None of the above
E None of the above Thyroid function tests are relatively easy to interpret with a basic understanding of the hypothalamic–pituitary–thyroid axis of thyroid hormone control. The pituitary produces TSH (thyroid stimulating hormone) which is released from the anterior pituitary. It is under the control of the hypothalamus which releases thyroid releasing hormone (TRH) which signals to anterior pituitary cells to release TSH. TSH travels in the bloodstream and acts on thyrocytes in the thyroid gland to stimulate production of T4 and T3 hormone. Specifically TSH controls the rate of iodide uptake required for thyroid hormone production, thyroid peroxidase activity, iodotyrosine reuptake into the thyrocyte from colloid and iodotyrosine cleavage to form mature hormone. T4 is the main circulatory hormone produced in about a 10:1 ratio compared with T3. However, free T3 has greater efficacy; in fact circulating T4 is converted into T3 within cells which then binds to its hormone receptor. TSH release is under negative feedback control of T4. In primary hypothyroidism, the thyroid does not have the ability to produce sufficient T4 or T3 to inhibit further TSH release. Therefore the biochemical abnormality found in primary hypothyroidism is a raised TSH with low T4 and T3, which is not one of the answer options (E).
Sodium handling A Ethanol B SIADH C Frusemide D Chronic kidney disease E Conn’s syndrome F Diarrhoea G Congestive cardiac failure H Addison’s disease I Hyperlipidaemia A 30-year old woman is seen by her GP after a 5-day episode of productive cough and lethargy. The GP notes dullness on percussion of the patient’s left lower lung. Blood and urine tests reveal the following: Na 128 (135–145 mmol/L) K 4.1 (3.5–5.0 mmol/L) Urea 3.5 (3.0–7.0 mmol/L) Glucose 3.2 (2.2–5.5 mmol/L) Osmolality 265 (275–295 mOsm/kg) Urine osmolality 285 mOsm/kg
B SIADH The syndrome of inappropriate ADH secretion (B; SIADH) results from the excess release of ADH. In this case the clinical features suggest pneumonia is the cause, but the aetiologies of SIADH are numerous, including malignancy, meningitis and drugs (carbamazepine). Criteria to diagnose SIADH include the following: • Hyponatraemia 100 mmol/L • High urine sodium >20 mmol/L • Euvolaemia • No adrenal, renal or thyroid dysfunction Characteristically the urine osmolality is inappropriately high; in normal circumstances if the plasma osmolality is low, the urine osmolality will stop rising as reduced ADH secretion prevents water retention. As a rule of thumb in SIADH, urine osmolality is greater than plasma osmolality.
Calcium handling A Primary hyperparathyroidism B Secondary hyperparathyroidism C Tertiary hyperparathyroidism D Pseudohypoparathyroidism E Primary hypoparathyroidism F Osteoporosis G Osteomalacia H Paget’s disease I Familial benign hypercalcaemia Ca 1.8 (2.2–2.6 mmol/L) PTH 0.69 (0.8–8.5 pmol/L) ALP 89 (30–150 u/L) PO4 1.5 (0.8–1.2 mmol/L) Vitamin D 76 (60–105 nmol/L)
E Primary hypoparathyroidism Primary hypoparathyroidism (E) is defined as dysfunction of the parathyroid glands leading to reduced production of PTH. As a result, the actions of PTH are blunted leading to reduced bone resorption as well as renal and gut calcium reabsorption. As a consequence there is hypocalcaemia and hyperphosphataemia. Other causes of hypocalcaemia include pseudoparathyroidism, vitamin D deficiency, renal disease (unable to make 1,25-dihydroxyvitamin D3), magnesium deficiency (magnesium required for PTH rise) and post-surgical (neck surgery may damage parathyroid glands).
- Arterial blood gas sample A 67-year-old woman presents to accident and emergency after having a fall. She is diagnosed with a fractured neck of femur which is fixed with a hemiarthroplasty. She also suffers from metastatic breast cancer. Four days postoperatively, she develops shortness of breath with an increased respiratory rate of 24 breaths per minute. The doctor on call takes an arterial blood gas sample which shows the following results: pH 7.48 PaO2 15.4 kPa on 2 L of oxygen pCO2 2.6 kPa Base excess +1 Saturations 99 per cent What does the blood gas show? A Metabolic alkalosis with respiratory compensation B Metabolic alkalosis C Respiratory alkalosis with metabolic compensation D Respiratory alkalosis E None of the above
D Respiratory alkalosis This lady has most likely suffered a pulmonary embolism manifesting as an acute onset of shortness of breath. Acid–base questions are best approached in three steps: first, decide if the pH shows an alkalosis or an acidosis. Next look at the PaCO2 and decide if it is high or low. Carbon dioxide dissolves in water to form carbonic acid, a weak acid. Therefore, if the concentration of carbon dioxide is high, it will lower the pH. You must then decide if the PaCO2 is compounding or helping the patient’s pH – in other words, is it worsening an acidotic patient or compensating for an alkalotic patient? Finally, look at the base excess. A greater positive base excess implies a higher concentration of bicarbonate, which is a base. Unlike carbon dioxide, therefore, high levels of bicarbonate will raise the pH. In this scenario, the pH is 7.48 meaning the patient is alkalotic with a low PaCO2, implying a respiratory cause. There is no compensation as the base excess of +1 is within normal limits. Unlike respiratory compensation, metabolic compensation takes several days. Below is a table of common causes of the different acid–base abnormalities with the likely carbon dioxide and base excess values.
Therapeutic drug monitoring A Procainamide B Lithium C Methotrexate D Theophylline E Gentamicin F Carbamazepine G Cyclosporine H Phenytoin I Digoxin A 65-year-old man being treated as an inpatient develops sudden onset ‘ringing in his ears’ as well as difficulty hearing.
E Gentamicin Gentamicin (E) is an aminoglycoside antibiotic, particularly useful against Gram-negative bacteria. It exhibits a low therapeutic index. Factors that may potentiate toxicity include dosage, kidney function (gentamicin is excreted through the kidneys) and other medications such as vancomycin. Gentamicin is an ototoxic and nephrotoxic agent and hence toxicity can lead to deafness and renal failure. Toxic effects on the ear are not limited to hearing, as the vestibular system is also affected, which may cause problems with balance and vision.
Endocrine chemical pathology A Prolactinoma B Grave’s disease C Addison’s disease D Schmidst’s syndrome E Acromegaly F Conn’s syndrome G Kallman’s syndrome H Secondary hypoaldosteronism I De Quervain’s thyroiditis A 45-year-old woman is referred to an endocrinologist due to the appearance of enlarged hands and feet as well as a protruding jaw. After conducting an oral glucose tolerance test, growth hormone levels are found to be 5 mU/L (
E Acromegaly Acromegaly (E) is caused by the increased secretion of growth hormone as a result of a pituitary adenoma (rarely there may be ectopic production). Serum growth hormone levels are not a useful marker of acromegaly due to its pulsatile release from the pituitary. The diagnostic test for acromegaly is the oral glucose tolerance test with synchronous growth hormone measurement: 75 mg of glucose is administered to the patient; if growth hormone levels are not suppressed to below 2 mU/L, a diagnosis of acromegaly is made.
Sodium handling A Ethanol B SIADH C Frusemide D Chronic kidney disease E Conn’s syndrome F Diarrhoea G Congestive cardiac failure H Addison’s disease I Hyperlipidaemia A 50-year-old woman with known diabetes has a routine blood test which demonstrates the following: Na 130 (135–145 mmol/L) K 4.1 (3.5–5.0 mmol/L) Urea 4.2 (3.0–7.0 mmol/L) Glucose 3.1 (2.2–5.5 mmol/L) Osmolality 283 (275–295 mOsm/kg)
I Hyperlipidaemia Pseudo-hyponatraemia can occur in patients with hyperlipidaemia (I) or hyperproteinaemia. In such states, lipids and proteins will occupy a high proportion of the total serum volume. Although the sodium concentration in serum water is in fact normal, a lower sodium concentration will be detected due to dilution by increased lipids and protein molecules. As a consequence, there is an apparent hyponatraemia. A spurious result due to the sample being taken from the drip arm can also cause pseudo-hyponatraemia.
Potassium handling A Spurious sample B Anorexia C Diarrhoea D Renal tubular acidosis E Insulin overdose F Bartter syndrome G Frusemide H Renal failure I ACE inhibitors A 64-year-old man who is an inpatient on the Care of the Elderly ward is found to have the following blood results: Na 136 (135–145 mmol/L) K 5.5 (3.5–5.0 mmol/L) Urea 14.4 (3.0–7.0 mmol/L) Creatinine 165 (60–120 mmol/L) pH 7.44 (7.35–7.45) HCO3 27 (22–28 mmol/L)
H Renal failure Renal failure (H) can lead to hyperkalaemia secondary to reduced distal renal delivery of sodium ions. As a consequence, there is reduced exchange of potassium ions via the Na/K ATPase pump in the collecting duct, which thereby leads to accumulation of potassium ions in the blood and hence hyperkalaemia. An increase in aldosterone release will initially cause a compensatory loss of potassium ions; as renal failure progresses, this homeostatic mechanism will become decompensated and hyperkalaemia will result. Renal failure will also be reflected in the deranged urea and creatinine levels due to reduced excretion.
Acute pancreatitis A 56-year-old presents with sudden onset, severe epigastric pain which radiates through to the back. The pain is relieved only partly by sitting forward and is associated with nausea. The admitting doctor suspects pancreatitis and sends for a serum amylase which is greatly raised. A diagnosis of acute pancreatitis is made. The following results come back following a blood test: Haemoglobin 14.5 g/dL White cells 14.2 Na 148 K 4.6 Urea 14 Creatinine 123 Calcium 2.98 (corrected) Cholesterol 5.5 Albumin 35 g/L Glucose 8.8 mmol/L Which biochemical abnormality is not likely to be a consequence of acute pancreatitis? A Raised white cells B Raised sodium C Raised urea and creatinine D Raised calcium E Raised glucose
D Raised calcium Hypercalcaemia is not a common consequence of acute pancreatitis, indeed hypercalcaenia is one of the causes of acute pancreatitis. Other causes of pancreatitis can be remembered by the well known mnemonic ‘GET SMASHED’: • Gallstones • Ethanol • Trauma • Steroids • Mumps • Autoimmune (polyarteritis nodosa) • Scorpion venom (Trinidadian scorpion) •Hypercalcaemia/Hypertriglyceridaemia/Hypothermia • Endoscopic retrograde cholangiopancreatogram • Drugs (including thiazides, azathioprine, valproate, oestrogens)
Acid–base balance A Metabolic acidosis B Metabolic acidosis with respiratory compensation C Metabolic alkalosis D Metabolic alkalosis with respiratory compensation E Respiratory acidosis F Respiratory acidosis with metabolic compensation G Respiratory alkalosis H Respiratory alkalosis with metabolic compensation I Mixed metabolic and respiratory acidosis pH 7.36 (7.35–7.45) pO2 14.2 (10.6–13 kPa) pCO2 4.1 (4.7–6.0 kPa) HCO3 14 (22–28 mmol/L)
B Metabolic acidosis with respiratory compensation Metabolic acidosis with respiratory compensation (B) occurs when pH is low (acidosis) and HCO3 is low with concurrent respiratory compensation by decreasing pCO2. The anion gap can differentiate between causes of metabolic acidosis (anion gap = [Na++ K+] – [Cl−+ HCO3 −]; normal range between 10 and 18 mmol/L). Causes of a raised anion gap can be remembered by the mnemonic MUDPILES: methanol/metformin, uraemia, diabetic ketoacidosis, paraldehyde, iron, lactate, ethanol and salicylates. Causes of a normal anion gap include diarrhoea, Addison’s disease and renal tubular acidosis.